January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 07, 2014

FDA MedWatch - Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall - Software Issue May Stop Ventilator


FDA MedWatch Nellcor Puritan Bennett 980 Ventilator System Class I Recall

October 25, 2014

FDA MedWatch - Intravia Containers by Baxter: Recall - Particulate Matter


FDA MedWatch Intravia Containers by Baxter Recall



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Congratulates Member Rafael Miguel, M.D. on his appointment to the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee

Friday, October 25, 2013

Rafael Miguel, M.D. was recently appointed to the U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee. This 13 member FDA Advisory Committee is charged with reviewing and evaluating data regarding the safety and effectiveness of drugs used in anesthesiology and surgery, and formulating recommendations to the commissioner of the FDA.

Dr. Miguel specializes in pain medicine and currently has a practice affiliated with the University of South Florida (USF) with clinics in Tampa and Sarasota in Florida. He has served as the president of the Florida Society of Anesthesiologists, chairman of the USF Department of Anesthesiology, and as vice-chair of the Florida Board of Medicine. Dr. Miguel attended medical school at the University of Cadiz in Cadiz Spain and completed his residency in anesthesiology at Tulane University.

ASA congratulates Dr. Miguel on his appointment.

Learn more about the FDA's Anesthetic and Analgesic Drug Products Advisory Committee.

« Back to Washington Alerts